Síndrome de ovario poliquístico

Polycystic ovary syndrome (PCOS) was a prevalent endocrine disorder in women, primarily causing hyperandrogenism (HA). It was a complex disorder influenced by genetic and environmental factors. Diagnosis was typically based on the Rotterdam Criteria, requiring 2 of 3 conditions: clinical or biochemical HA, chronic oligo-anovulation (OA), or polycystic ovaries, while excluding other causes. PCOS was often linked with metabolic issues like obesity and type 2 diabetes, and reproductive problems such as infertility. Treatment was tailored to individual symptoms and reproductive goals, with weight loss being crucial for overweight patients to restore menstrual cycles and reduce metabolic risks. Oral contraceptives were commonly used to manage HA and protect the endometrium, while clomiphene citrate was recommended for those seeking pregnancy. Metformin was an option for patients with glucose intolerance or type 2 diabetes, and as a secondary treatment to restore cycles and induce ovulation.